BRAF and RASopathy: This, along with the phenotypic differences of mouse models with different genetic backgrounds, suggests RASopathy-associated BRAF mutations exert heterogenous effects on downstream signaling pathways depending on the way each mutation interacts with each genetic background throughout development.